Next Article in Journal
The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone
Previous Article in Journal
Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia
 
 
Case Report

Article Versions Notes

Hematol. Rep. 2024, 16(4), 585-592; https://doi.org/10.3390/hematolrep16040057
Action Date Notes Link
article pdf uploaded. 27 September 2024 17:11 CEST Version of Record https://www.mdpi.com/2038-8330/16/4/57/pdf-vor
article xml file uploaded 29 September 2024 12:11 CEST Original file -
article xml uploaded. 29 September 2024 12:11 CEST Update https://www.mdpi.com/2038-8330/16/4/57/xml
article pdf uploaded. 29 September 2024 12:11 CEST Updated version of record https://www.mdpi.com/2038-8330/16/4/57/pdf
article html file updated 29 September 2024 12:13 CEST Original file https://www.mdpi.com/2038-8330/16/4/57/html
Back to TopTop